Repligen Corporation (RGEN) Cash on Hand per Share

Symbol and logo of brand Repligen Inc. (RGEN)

The stability of Repligen Corporation (RGEN) plants in Europe and the US guarantees the production of critical biocomponents. The cash per share calculation on GURU.Markets demonstrates financial resilience, where the 13.56 mark records this metric. Patents secure operations amid moderate external supply, while a strong staff of R&D engineers and targeted hiring in gene therapy eliminate personnel risks.

Repligen (RGEN) - Cash per Share from 07/04/2022 to 11/20/2026

Comprehensive metric breakdowns and analytics for Repligen Corp (RGEN)

- stock price and consensus target price:
- cash and cash flow data:
Comprehensive company analysis:RGEN (Repligen Inc.)
Finished products of Repligen

This indicator reflects the volume of liquid reserves per common share, allowing for an assessment of financial strength and the rate of capital consumption. Analyzing the cash per share metric is critically important for Repligen Corporation (RGEN), as liquidity funds R&D in the bioprocessing segment and the integration of new M&A assets, confirming the business's fundamental resilience to market cycles.

Analysis of competing companies

TEM (Tempus AI Inc) - Cash Calculated per Single Share|Cash per Share QGEN|IONS - Cash on Hand per Share|Cash Funds per Share Avidity RNA|Cash per Share CRISPR Therapeutics Corp CRSP|GeneDx Corp - Cash per Share|Ultragenyx Pharma (RARE) - Cash per Single Share|beamtx.com (BEAM) - Cash Funds per Share|SRPT: Cash Calculated per Single Share|Cash per Single Share TWST|TXG - Cash Funds Volume per Share|Cash per Share NTLA|Cash Funds Calculated per Share Stoke Therapeutics|Cash Funds per Share BioLife Solutions BLFS|Wave Life Sciences (WVE) - Cash on Hand per Share|Maze Therapeutics, Inc. - Cash per Share|Cash Funds Calculated per Share Sionna Therapeutics, Inc. SION|Prime Medicine Bio (PRME) - Cash Funds per Share|TSHA: Cash Calculated per Single Share|Cash Funds per Share uniQure Pharma|MGTX - Cash Funds Volume per Share|Cash per Share RGNX|Cash Funds per Share SLDB (Solid Biosciences)|Ocugen Corp - Cash per Single Share|PACB: Cash Funds per Single Share|benitec.com - Cash per Share|DSGN - Cash per Share|RCKT: Cash per Share|FDMT (4D Molecular Therapeutics Inc) - Cash Funds per Share|Cash per Single Share LXEO|Cash Funds per Share KRRO|Cash per Share EDIT|SLN - Cash on Hand per Share|Cash per Share PRQR (ProQR)|CDXS - Cash per Single Share|Sangamo Therapeutics Inc. - Cash per Share|NAUT - Cash per Share|MGX: Cash per Share|Cash per Single Share Precision BioSciences, Inc.|GBIO (Generation Bio) - Cash per Share|Boundless Bio Inc. (BOLD) - Cash Funds Calculated per Share|Cash per Single Share XCUR (exicuretx.com)|Imunon Inc - Cash Funds per Single Share|Cash per Share PHIO (Phio Pharmaceuticals Corp)|Amount of Cash per Share MBIO|RNAZ - Cash Funds per Share|Amount of Cash per Share BNGO (bionanogenomics.com)|Applied DNA Sciences (APDN) - Cash Funds per Share|Bluebird Bio - Amount of Cash per Share|IPA (ImmunoPrecise Antibodies Ltd) - Cash per Share|Cash on Hand per Share Omega Therapeutics, Inc. OMGA|Cash per Share OMIC|RGLS (Regulus Therapeutics Inc.) - Amount of Cash per Share|Cash per Share SYRS (Syros Pharmaceuticals Inc.)|Cash Calculated per Single Share TBIO (Codex DNA)|TCON - Cash Funds per Share|Cash on Hand per Share Unity Biotechnology